Bacterial infections are a huge problem, particularly in medical settings like hospitals. But one U.S. company, recently bought by a Chinese firm, has come up with a product that could provide a real answer: It all has to do with sharks.
Sharklet Technologies, Inc., a biotechnology company lauded for the creation and
commercialization of Sharklet®, the world’s first micro-texture that inhibits bacterial growth on surfaces,
today announced that it has completed a financing event led by Peaceful Union, an equity medical
device firm in Hangzhou, China. Terms of the transaction were not disclosed.
The acquisition of the company will enable Sharklet Technologies to accelerate the development of
Sharklet for medical devices where chemical-free bacterial inhibition is desired as well as high-touch
surfaces prone to bacterial contamination. The company also will accelerate development of a newly
enhanced wound dressing technology to encourage healing.
Download Full Press Release
Sharklet will be featured in the next episode of Xploration Nature Knows Best. Check your local TV listings to catch the episode.
Xploration Nature Knows Best
S01, E09 – Sharks’ skin is used to fight germs; sharks’ senses help to build better robots; wetsuits make people nearly invisible to the ocean’s top predators.
Click Here to find your specific air date, channel and time. You can click “Change My Location” then search “Xploration Nature Knows Best” in the search box.
When patients are mechanically ventilated, endotracheal tubes have the potential to disrupt normal airway secretion production and clearance. This ultimately results in secretion accumulation within standard endotracheal tubes and leads to numerous complications for the patient. Sharklet has developed two different test models (in vitro and in vivo) to evaluate the ability of Sharklet-micropatterned endotracheal tubes to reduce the accumulation of these secretions and improve patient care.